Miragen Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, MGEN, Miragen Therapeutics Inc, priceseries

Miragen Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
17.90
Close
18.00
High
18.00
Low
16.79
Previous Close
18.39
Daily Price Gain
-0.39
YTD High
2247.75
YTD High Date
Jun 18, 2014
YTD Low
4.67
YTD Low Date
Mar 19, 2020
YTD Price Change
-2027.25
YTD Gain
-99.12%
52 Week High
18.89
52 Week High Date
Mar 15, 2021
52 Week Low
15.52
52 Week Low Date
Mar 8, 2021
52 Week Price Change
1.31
52 Week Gain
7.85%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 12. 2017
143.70
Jan 18. 2017
153.82
3 Trading Days
7.05%
Link
LONG
Feb 3. 2017
147.90
Feb 13. 2017
170.18
6 Trading Days
15.06%
Link
LONG
Jul 7. 2017
195.45
Jul 21. 2017
216.14
10 Trading Days
10.59%
Link
LONG
Mar 2. 2018
87.90
Mar 23. 2018
108.80
15 Trading Days
23.77%
Link
LONG
May 1. 2018
103.35
May 17. 2018
109.31
12 Trading Days
5.77%
Link
LONG
Dec 31. 2018
45.45
Jan 10. 2019
49.77
7 Trading Days
9.52%
Link
LONG
Mar 13. 2019
39.75
Mar 25. 2019
44.10
8 Trading Days
10.94%
Link
LONG
Jan 3. 2020
8.01
Jan 21. 2020
9.06
11 Trading Days
13.03%
Link
LONG
Jan 23. 2020
10.20
Feb 4. 2020
19.19
8 Trading Days
88.19%
Link
LONG
Apr 9. 2020
6.92
Apr 15. 2020
7.43
3 Trading Days
7.43%
Link
LONG
Apr 23. 2020
8.40
Apr 30. 2020
8.87
5 Trading Days
5.55%
Link
LONG
May 26. 2020
10.24
Jun 4. 2020
12.73
7 Trading Days
24.27%
Link
LONG
Jun 19. 2020
19.05
Jun 23. 2020
21.45
2 Trading Days
12.60%
Link
LONG
Dec 7. 2020
17.06
Dec 23. 2020
18.32
12 Trading Days
7.38%
Link
LONG
Jan 7. 2021
18.40
Jan 20. 2021
20.73
8 Trading Days
12.65%
Link
Company Information
Stock Symbol
MGEN
Exchange
NasdaqCM
Company URL
http://http://www.signalgenetics.com
Company Phone
303-531-5952
CEO
Samuel D. Riccitelli
Headquarters
Colorado
Business Address
6200 LOOKOUT ROAD, BOULDER, CO 80301
Sector
Equity
Industry Category
-
Industry Group
-
CIK
0001590750
About

Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer.

Description

Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer. The company primarily offers Myeloma Prognostic Risk Signature (MyPRS) test, a microarray-based gene expression profiling assay that tests for the presence of specific groups of genes that could predict low or high level risk of early relapse in patients suffering from multiple myeloma. Signal Genetics, Inc. was founded in 2010 and is headquartered in Carlsbad, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading